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Abstract 
Background  and  purpose:  A  linkage  between  the  neurotransmitter  alpha-calcitonin 
gene-related peptide (alpha-CGRP)  and  particle-induced osteolysis has been shown previ-
ously. The suggested osteoprotective influence of alpha-C G R P   o n   t h e   c a t a b o l i c   e f f e c t s   o f  
ultra-high molecular weight polyethylene (UHMWPE) particles is analyzed in this study in 
primary  human  osteoblasts.  Methods:  Primary  human  osteoblasts  were  stimulated  by 
UHMWPE particles (cell/particle ratios 1:100 and 1:500) and different doses of alpha-CGRP 
(10
-7 M, 10
-9 M, 10
-11 M). Receptor activator of nuclear factor-κB ligand (RANKL)  and os-
teoprotegerin (OPG) mRNA expression and protein levels were measured by RT-PCR and 
Western blot. Results: Particle stimulation leads to a significant dose-dependent increase of 
RANKL m R N A   i n   b o t h   c e l l -particle ratios and a significant down-r e g u l a t i o n   o f   O P G   m R N A   i n  
cell-particle concentrations of 1:500. A significant depression of alkaline phosphatase was 
found due to particle stimulation. Alpha-CGRP in all tested concentrations showed a signif-
icant depressive effect on the expression of RANKL mRNA in primary human osteoblasts 
under particle stimulation. Comparable reactions of RANKL protein levels due to particles 
and alpha-C G R P   w e r e   f o u n d   b y   W e s t e r n   b l o t   a n a l y s i s .   I n   c e l l -p a r t i c l e   r a t i o s   o f   1 : 1 0 0   a f t e r   2 4  
hours the osteoprotective influence of alpha-CGRP reversed the catabolic effects of particles 
on the RANKL expression. Interpretation: The in-vivo use of alpha-CGRP, which leads to 
down-r e g u l a t e d   R A N K L   i n -vitro, might inhibit the catabolic effect of particles in conditions of 
particle induced osteolysis. 
Key words: Aseptic loosening, polyethylene, alpha-CGRP, hOB, RANKL. 
Introduction 
M e c h a n i c a l   w e a r   i n   t h e   j o i n t   o f   a   t o t a l   h i p   r e-
placement  induces  a  severe  inflammatory  reaction 
leading to aseptic prosthetic loosening [1]. A linkage 
between  the  nervous  system  and  aseptic  loosening 
has been discussed since the discovery of calcitonin 
gene-related  peptide  (CGRP)-immunoreactive  nerve 
fibres in the interface membrane of loosened arthro-
plasty  [2].  In  our  previous  in-vivo  study  of  al-
pha-CGRP  knock-out  mice  w e   f o u n d   a  
down-regulation  of  osteogenesis  and  osteolysis  that 
were  partly  mediated  via  the  osteoprotege-
rin/receptor  activator  of  nuclear  factor-κB  li-
gand/receptor  activator  of  nuclear  factor-κB 
(OPG/RANKL/RANK) system [3]. Alpha-CGRP is a Int. J. Biol. Sci. 2010, 6 
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neurotransmitter  and  transmembrane  protein  with 
multiple physiological roles. It affects the metabolism 
of the skeletal muscle, the liver and the kidneys, and 
i n h i b i t s   g l y c o g e n   s y n t h e s i s   [ 4 ,   5 ] .   I t   a c t s   a s   a   p o t e n t  
vasodilatator, as a neurotrophic e f f e c t o r   a n d   a s   a   m e-
diator in the neurogenic inflammatory response [6, 7]. 
T h e   O P G / R A N K L / R A N K   s y s t e m   p l a y s   a   k e y   r o l e   i n  
the cross-talk between osteoblasts and osteoclasts [8, 
9 ] .   R A N K L   a n d   O P G   a r e   m e m b e r s   o f   a   l i-
gand-receptor  system  that  directly  regulates osteoc-
last differentiation and bone resorption, and both are 
produced and secreted by osteoblastic lineage cells [9, 
1 0 ] .   R A N K L   b i n d s   t o   i t s   r e c e p t o r   R A N K ,   w h i c h   i s  
e x p r e s s e d   o n   o s t e o c l a s t   p r o g e n i t o r s ,   a n d   l e a d s   t o   o s-
teoclast activation. OPG binds to RANKL and thereby 
inhibits  osteoclast  activation.  Recent  in-vitro  studies 
of primary human osteoblasts (hOBs) showed an in-
c r e a s e   o f   R A N K L   e x p r e s s i o n   a n d   i n d u c t i o n   o f   a   c a-
tabolic  phenotype  by  ultra-high  molecular  weight 
polyethylene (UHMWPE) particles [11, 12].  
To  closer  study  the  direct  influence  of  al-
pha-C G R P   o n   b o n e   m e t a b o l i s m ,   w e   a n a l y z e d   t h e   e x-
pression of RANKL and OPG in hOBs hypothesizing 
an  osteoprotective  influence  of  alpha-C G R P   i n   t h e  
presence of wear particles in-vitro.  
Patients and Methods 
Peptide 
Alpha-C G R P   ( S i g m a   A l d r i c h ,   C a t .   N o .   C 0 1 6 7 ,  
Saint  Louis,  Missouri,  USA)  was  dissolved  in  1% 
acetic acid or water and stored at -20° Celsius before 
use.  During  cell  seeding,  alpha-CGRP  was  added 
d a i l y   t o   t h e   e x p e r i m e n t a l   w e l l s   t o   f o r m   d i f f e r e n t   c o n-
centrations (10-7 M, 10-9 M or 10-11 M), as introduced 
by Villa et al. while an alpha-CGRP-free medium was 
added to the control group [13]. 
Preparation of wear particles 
The commercially pure UHMWPE particles (Ce-
r i d u s t   V P   3 6 1 0 ,   C l a r i a n t ,   G e r s t h o f e n ,   G e r m a n y )   w i t h   a  
mean particle size (given as equivalent circle diame-
ter) of 1.74 ± 1.43 μm (range 0.05-11.06) were used in 
t h i s   s t u d y   [ 1 4 ] .   F o r   e n d o t o x i n   r e m o v a l ,   t h e   p a r t i c l e s  
w e r e   t r e a t e d   f o r   2 4   h o u r s   w i t h   9 9 %   e t h a n o l   a t   r o o m  
temperature and dried in a desiccator. The efficiency 
o f   t h e   m e t h o d   w a s   c h e c k e d   u s i n g   L i m u l u s   A m e b o c y t e  
Lysate  (LAL)  Assay  (Charles  River,  Kent,  United 
K i n g d o m )   w i t h   a   s e n s i t i v i t y   o f   0 . 2 5   E U / m l   a c c o r d i n g  
to the manufacturer’s directions. The test was found 
to  be  negative.  Subsequently,  particles  were 
re-s u s p e n d e d   i n   1 0 %   e n d o t o x i n -free fetal calf serum 
(FCS), vortexed and treated in a sonicating water bath. 
F l o w   c y t o m e t r y   w a s   u s e d   t o   m e a s u r e   t h e   n u m b e r   o f  
particles per unit volume of solution.  
Primary human osteoblasts 
Explants  from  the  upper  femur  were  obtained 
f r o m   5   p a t i e n t s   u n d e r g o i n g   a r t h r o p l a s t y   f o r   f r a c t u r e d  
neck of femur analog to comparable publications [13, 
15-1 8 ] .   T h e   d o n o r s   o f   t h i s   s t u d y  aged 57 to 64 years. 
T h e y   d i d   n o t   s u f f e r   f r o m   k n o w n  metabolic or systemic 
diseases and did  not  take any drugs affecting bone 
metabolism. All donors gave their informed consent 
prior to their inclusion in the study. Osteoblastic cells 
from  cancellous  bone  fragments  were  obtained  by 
enzymatic digestion using type II collagenase (Gibco 
BRL Life Technologies, Eggenstein, Germany) as de-
s c r i b e d   b y   B e l o t i   e t   a l .   [ 1 9 ] .   T h e s e   c e l l s   w e r e   c u l t u r e d  
in  α-minimum  essential  medium  (Gibco),  supple-
mented  with  10%  fetal  bovine  serum  (Gibco), 
50ug/mL  vancomycin  ( A c r o s   O r g a n i c s ,   G e l l ,   B e l-
gium),  20ug/mL  ampicillin  (USB  Corp.,  Cleveland, 
USA),  0.3  mg/mL  fungizone  (Gibco),  10
-7M  dex-
amethazone (Sigma, St.  Louis,  USA), 50 µg/mL  as-
corbic  acid  (Gibco),  and  7  mmol/L  β
-glycerophosphate  (Sigma).  Subconfluent  cells  in 
primary  c u l t u r e  were  harvested  after  t r e a t m e n t 
with  1  mmol/L  ethylenediamine  tetracetic  acid 
(Gibco) and 0.25% trypsin (Gibco) and subcultured 
in 24-well culture plates (Falcon, Franklin Lakes, NJ) 
at a cell density o f   2 x104 cells/well in culture medium. 
During  the  culture  period,  cells  were  incubated  at 
37°C  in a humidified  atmosphere of 5% CO2  and 
the medium  was changed  every 3 days. We identi-
fied the hOBs by alkaline phosphatase staining, von 
Kossa staining and alizarin red staining. 
For the experiment, hOB cells were seeded into 
6-well flat bottomed culture plates at the quantity of 
approximately 1.5×105 cells per well. After 24 hours, 
a n   8 0 %   c o n f l u e n c e   o f   t h e   c e l l s   w a s   r e a c h e d .   T h e   s u-
pernatant  was  removed  and  a  fresh  medium  con-
taining  UHMWPE  particles  was added.  The  hydro-
phobicity of polyethylene was addressed by inverted 
cell-culturing procedures analog to Fang  et al. to al-
low  contact  of  hOBs  and  UHMWPE  particles  [20]. 
During this procedure, different quantities of particles 
were added to form two different cell-particle ratios 
(1:100 and 1:500).  
Isolation of RNA and quantitative Real Time RT-PCR 
analysis 
Total  RNA  was  isolated  using  Qiashredder 
(Qiagen,  H i l d e n ,   G e r m a n y )   a n d   p u r i f i e d   u s i n g   t h e  
R N e a s y   M i n i   K i t   ( Q i a g e n ,   H i l d e n ,   G e r m a n y ) .   B o t h  
procedures were performed according to the manu-
facturer’s  specification.  The  purification  included  a 
D N a s e   t r e a t m e n t   u s i n g   t h e   R N a s e   f r e e   D N a s e   S e t  
(Qiagen,  Hilden,  Ger m a n y ) .   T h e   y i e l d   a n d   p u r i t y   o f  Int. J. Biol. Sci. 2010, 6 
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t h e   R N A   w a s   m e a s u r e d   p h o t o m e t r i c a l l y .   R N A   w a s  
analyzed by quantitative real time polymerase chain 
reaction  (RT-PCR)  in  a  Rotorgene  Cycler  (Corbett 
Research, Mortlake, Australia) using the QuantiFast 
SYBR Green RT-P C R   k i t   ( Q i agen, Hilden, Germany) 
a c c o r d i n g   t o   t h e   m a n u f a c t u r e r ’ s   i n s t r u c t i o n s .   A   c o n-
v e n t i o n a l   P C R   w a s   p e r f o r m e d   t o   o b t a i n   a   p r o d u c t   o f  
amplification suitable for the construction of standard 
curves  with  the  real-t i m e   P C R   p r o c e d u r e s .   T h e   i n-
corporation of Sybr Green into the PCR products was 
monitored in real time after each PCR cycle, resulting 
i n   t h e   c a l c u l a t i o n   o f   t h e   t h r e s h o l d   c y c l e   o r   C t value 
t h a t   d e f i n e s   t h e   P C R   c y c l e   n u m b e r   a t   w h i c h   a n   e x p o-
n e n t i a l   g r o w t h   o f   P C R   p r o d u c t s   b e g i n s .   P C R   c y c l e  
conditions were as follo w s :   1 0   m i n u t e s   a t   5 0 ° C ,   5   m i-
n u t e s   a t   9 5 ° C ,   3 5   t o   4 0   c y c l e s   o f   1 0   s e c o n d s   a t   9 5 ° C   a n d  
30 seconds at 60°C. Each PCR procedure included a 
negative control reaction without a template. To ex-
c l u d e   r e s i d u a l   D N A   c o n t a m i n a t i o n   o f   t h e   R N A   s a m-
ples,  RT-PCR  was  also  performed  without  reverse 
transcriptase. For mRNA amplification, the validated 
primers were obtained from Qiagen (Qiagen, Hilden, 
Germany):  ß-actin  (Cat.  No.  QT00095431),  RANKL 
(Cat.  No.  QT00215614)  and  OPG  (Cat.  No. 
QT00014294). The PCR products were sequenced and 
f o u n d   t o   b e   i d e n t i c a l   t o   t h e   p u b l i s h e d   s e q u e n c e s .   T h e  
ß-actin housekeeping gene was used as reference for 
the  relative  quantification  of  the  gene  of  interest, 
w h i c h   w a s   e x p r e s s e d   a s   t h e   r a t i o   o f   ‘ c o n c e n t r a t i o n   o f  
the target’ to ‘concentration of ß-actin’.  
Western Blot 
HOBs  were  stimulated  with  and  without  par-
ticles (the cell-particle ratios were 1:100 and 1:500 re-
spectively)  f o r   2 4 ,   4 8   a n d   7 2   h o u r s .   T h e   c e l l s   w e r e  
washed twice with ice-cold phosphate-buffered saline 
(PBS) and directly lysed in Laemmli buffer. The lysate 
was sonicated, boiled for 5 minutes and centrifuged at 
16,000 g for 10 minutes at 4°C. The supernatant was 
recovered as total cell lysate, sub-packaged and stored 
at -8 0 ° C .   E q u a l   a m o u n t s   o f   p r o t e i n   ( 1 0   μ g )   w e r e   s e-
p a r a t e d   b y   8 %   S D S -PAGE and electro-transferred to 
0.45 μm polyvinylidene difluoride membranes (Mil-
lipore, Bedford, USA). Following transfer, membranes 
w e r e   b l o c k e d   w i t h   a   s o l u t i o n   o f   0 . 1 %   T w e e n   2 0 / T B S  
(TBS/T) containing 5% non-f a t   m i l k   f o r   o n e   h o u r   a t  
room temperature and then  incubated  with  monoc-
lonal  mouse  anti-human  OPG  antibody  (GTX11994, 
G e n e T e x ,   U S A ,   f i n a l   d i l u t i o n   1 : 3 0 0 )   o r   r a b b i t   p o l y c-
lonal human RANKL (AB1862, Chemicon, Temecula, 
California,  USA,  final  dilution  1:3500)  overnight  at 
4°C.  Specifically  bounded  primary  antibodies  were 
detected with peroxidase-coupled secondary antibo-
dy and enhanced chemiluminescence (Cell Signaling 
Technologies, Beverly, MA). The bands were visua-
lized  by  nitroblue  tetrazolium/5-bromo-4-chloro- 
3-indolyl-phosphate.  Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) was used as house-keeping 
gene.  
For densitometric analyzes, blots were scanned 
and quantiﬁed using Quantity One analysis software 
(Bio-Rad, Hercules,  CA,  USA). The results were ex-
pressed  as  the  percentage  of  GAPDH  immunoreac-
tivity. 
Alkaline phosphatase speciﬁc activity 
Upon  termination  of  culture,  the  medium  was 
carefully aspirated from each well. The QuantiChro-
meTM  Alkaline  Phosphatase  Assay  Kit  (Cat.  No. 
DALP-250;  BioAssay  Systems,  Hayward,  CA)  was 
used  to  measure  alkaline  phosphatase  (AP)  activity 
levels in  lysate samples of 104 cells,  following the 
manufacturer’s instructions.  
Statistical analysis 
Results  from  representative  experiments  are 
shown.  They  were  expressed  as  mean  ±  standard 
deviation. A repeated measurement ANOVA  for  all 
continuous dependent variables determined if there 
was (a) a time-by-group interaction effect, (b) a time 
effect and (c) inter-group effect. When F-values  cor-
r e s p o n d i n g   t o   a   t i m e -by-group interaction effect for a 
given  variable  were  found  to  be significant, simple 
effects  testing  was  performed  to  determine  a  time 
effect within each experimental group. Subsequently, 
one-way ANOVA tests were used to determine the 
detectable  change  between  the  groups  at  each  time 
point. One-way ANOVA tests, at eac h   t i m e   p o i n t   r e l-
ative to the previous time point, determined if there 
were  significant  changes  from  each  time-point.  A 
p-value<0.05  was  considered  to  indicate  statistical 
significance.  
Ethics 
The study was performed in accordance with the 
ethical standards laid down in the Helsinki Declara-
tion of 1975, as revised in 2008. 
Results 
HOBs  without  co-incubation  of  particles  and 
alpha-C G R P   d i d   n o t   s h o w   t i m e -dependent  differ-
ences in RANKL mRNA expression.  
A f t e r   2 4   h o u r s   n o   e f f e c t s   o f   p a r t i c l e s   w e r e   f o u n d  
(Figure   1 ) .   A f t e r   4 8   h o u r s   h i g h   ( 1 : 5 0 0 )   c e l l -particle 
concentrations  lead  to  a  significant  increase  of 
R A N K L   m R N A   c o m p a r e d   t o   t h e   s h a m   g r o u p  
( p < 0 . 0 5 ) .   A f t e r   7 2   h o u r s ,   t h e   R A N K L   m R N A   e x p r e s-
sion  was  significantly  (p<0.05)  increased  at Int. J. Biol. Sci. 2010, 6 
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cell-particle  concentrations  of  1:100  and  1:500  com-
p a r e d   t o   t h e   s h a m   g r o u p .   F u r t h e r m o r e ,   h i g h  
cell-particle concentrations (1:500) lead to a signifi-
cantly  (p<0.05)  higher  RANKL  mRNA  expression 
compared to cell-particle concentrations of 1:100. 
Alpha-CGRP  treatment  of  the  particle  treated 
h O B s   l e a d   t o   a   d o w n -r e g u l a t i o n   o f   R A N K L   m R N A  
(Figure  2).  In  cell-particle  ratios  of  1:100,  RANKL 
mRNA expression was significantly decreased by all 
concentrations  of  alpha-CGRP  at  all  time  points 
(p<0.05) (Figure 2a). I n   p a r t i c l e   c o n c e n t r a t i o n s   o f   1 : 5 0 0 
no effect of alpha-C G R P   o n   R A N K L   m R N A   w a s   d e-
t e c t e d   a t   2 4   h o u r s ,   w h e r e a s   a t   4 8   h o u r s   a n d   7 2   h o u r s  
RANKL  mRNA  levels  were  significantly  decreased 
(p<0.05) (Figure 2b). The down-r e g u l a t i o n   o f   R A N K L  
m R N A   e x p r e s s i o n   d u e   t o   a l p h a -C G R P   w a s   n o t   i n-
fluenced by the tested concentrations of 10-7 M, 10-9 M 
or 10-11 M (Figure 2). 
The  detected  RANKL  protein  levels  corre-
sponded  to  the  mRNA  expression.  A  significantly 
decreasing  RANKL/GAPDH  ratio  was  found  after 
alpha-CGRP incubation in both cell-particle ratios at 
48 h o u r s   a n d   7 2   h o u r s   ( F i g u r e   3 ) .   T h e   t e s t e d   c o n c e n-
trations  of  alpha-CGRP  (10-7 M, 10-9 M and 10-11 M) 
s h o w e d   n o   i n f l u e n c e   o n   t h e   d e c r e a s e   o f   R A N K L   p r o-
tein levels (results not shown). 
P a r t i c l e   t r e a t m e n t   o f   h O B s   d i d   n o t   l e a d   t o   s i g-
n i f i c a n t   c h a n g e s   o f   O P G   m R N A   expression  after  24 
a n d   4 8   h o u r s .   I n   c e l l -particle concentrations of 1:500 a 
s i g n i f i c a n t   d e c r e a s e   o f   O P G   m R N A   w a s   f o u n d   ( F i g u r e  
4).  
Alpha-CGRP treatment of the particle incubated 
h O B s   d i d   n o t   s h o w   a n   e f f e c t   o n   O P G   m R N A   c o m-
pared to the sham groups (Figure 5). 
The OPG protein levels detected by Western blot 
analysis corresponded to the mRNA expression (Fig-
u r e   6 ) .   A   s i g n i f i c a n t   d o w n -r e g u l a t i o n   o f   O P G   w a s  
found after particle incubation with cell-particle ratios 
of  1:500.  Alpha-CGRP  substitution  did  not  lead  to 
significant changes in any groups. 
AP  activity  was  measured  to  further  show  the 
influence of particle dose and alpha-CGRP concentra-
t i o n   o n   t h e   a c t i v i t y   o f   h O B s .   T h e   u n t r e a t e d   h O B s   h a d  
an AP activity of 22.4 IU/L ± 4.67 IU/L. AP activity in 
cells treated with cell-particle ratios of 1:100 and 1:500 
was significantly (p<0.05) decreased compared to the 
control at all time points.  
AP activity after alpha-CGRP treatment did not 
d i f f e r   f r o m   t h e   c o r r e s p o n d i n g   g r o u p   w i t h o u t   a l-
pha-CGRP treatment (Table 1).  
 
Figure 1 RANKL mRNA expression of hOBs after stimulation with different UHMWPE particle concentrations. Data are 
reported as mean ± standard deviation. Significant differences are marked. ((a) p<0.05).  
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Figure 2 T i m e   c o u r s e   o f   R A N K L   m R N A   e x p r e s s i o n   i n   h O B s   a f t e r   t r e a t m e n t   w i t h   d i f f e r e n t   alpha-C G R P   d o s e s .   T h e   r a t i o s  
of particle-s t i m u l a t e d   h O B s   a n d   t h e   c o r r e s p o n d i n g   i n c u b a t i o n   w i t h o u t   p a r t i c l e   t r e a t m e n t   a r e   s h o w n .   D a t a   a r e   r e p o r t e d   a s  
mean ± standard deviation. Significant differences are marked. ((a) p<0.05). a Cell-particle ratio of 1:100 b Cell-particle ratio 
of 1:500  
 Int. J. Biol. Sci. 2010, 6 
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F i g u r e   3  Time courses of RANKL protein levels in hOBs stimulated by UHMWPE particles and alpha-CGRP using Western 
blot analysis. a Representative Western blot for RANKL in the untreated group and the alpha-CGRP-incubated groups b 
Densitometric quantiﬁcation of RANKL in particle-treated (particle concentrations of 1:100 and 1:500) group with and 
without alpha-CGRP incubation. RANKL protein levels are expressed relatively to GAPDH. Data are reported as mean ± 
standard deviation (n=5) ((a) p<0.05). Int. J. Biol. Sci. 2010, 6 
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Figure 4 OPG mRNA expression of hOBs after stimulation with different UHMWPE particle concentrations. Data are 
reported as mean ± standard deviation. Significant differences are marked. ((a) p<0.05).  
 
Figure  5  Time  course  of  UHMWPE 
particle-induced OPG mRNA expres-
sion after treatment with different al-
pha-C G R P   d o s e s .   T h e   r a t i o s   o f   p a r-
ticle-stimulated hOBs and the corres-
ponding  incubation  without  particle 
t r e a t m e n t   a r e   s h o w n .   D a t a   a r e   r e-
ported as mean ± standard deviation. 
Significant differences are marked. ((a) 
p<0.05). a Cell-particle ratio of 1:100 b 
Cell-particle ratio of 1:500.  Int. J. Biol. Sci. 2010, 6 
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Figure 6 Time courses of OPG protein levels in hOBs stimulated by UHMWPE particles and alpha-CGRP using Western 
blot analysis. GAPDH protein levels serve as control. OPG protein levels are expressed relatively to GAPDH. Data are 
reported as mean ± standard deviation. ((a) p<0.05). a Representative Western blots for OPG in untreated group and the 
alpha-CGRP-incubated groups. b Densitometric quantiﬁcation of OPG in particle-treated (particle concentrations of 1:100 
and 1:500) group with and without alpha-CGRP incubation. OPG protein levels are expressed relatively to GAPDH. Data 
are reported as mean ± standard deviation. (n=5) ((a) p<0.05).  
 Int. J. Biol. Sci. 2010, 6 
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Table 1 A l kaline phosph a t a s e   s p e cific activity of hOBs incubated with different cell-particle ratios (1:100, 1:500) and 
different doses of alpha-C G R P   ( 1 0
-7 M ,   1 0
-9 M ,   1 0
-11 M ) .   T reatment/control ratios ( T / C )   a r e   s h own. Data are reported as 
mean ± standard deviation. Significant differences between treated and control group are shown. ((a) p<0.05). 
 
 
1:100  
(a)  
1:100  
10-11 M CGRP 
(a) 
1:100 
10-9 M CGRP 
(a) 
1:100 
10-7 M CGRP 
(a) 
1:500  
(a) 
1:500  
10-11 M CGRP 
(a) 
1:500 
10-9 M CGRP 
(a) 
1:500 
10-7 M CGRP 
(a) 
24HR  0.80±0.03  0.78±0.04  0.77±0.03  0.82±0.03  0.73±0.02  0.72±0.03  0.71±0.04  0.73±0.04 
48HR  0.78±0.03  0.77±0.03  0.77±0.04  0.80±0.04  0.71±0.03  0.70±0.05  0.71±0.03  0.71±0.04 
72HR  0.78±0.03  0.77±0.04  0.75±0.04  0.79±0.04  0.66±0.03  0.69±0.04  0.69±0.02  0.66±0.02 
 
 
Discussion 
U n t i l   n o w   t h e   e f f e c t s   o f   a l p h a -C G R P   i n   p o l y e-
thylene particle-induced osteolysis have not been de-
scribed  in  hOBs.  For  in-vitro  study  of  osteoblast 
model systems, hOBs are widely regarded as standard 
procedure for analyzing osteoblasts as they are grown 
from biopted bone fragments [13, 21-23]. We believe 
that this is the first time that the effect of alpha-CGRP 
o n   R A N K L   a n d   O P G   e x p r e s s i on has been examined 
in hOBs under particle incubation.  
This in vitro study of hOBs showed a possible 
osteoprotective influence of alpha-CGRP on hOBs in 
conditions  of  UHMWPE  particle  stimulation. 
UHMWPE  particles  caused  a  significant 
dose-dependent  increase in  RANKL mRNA  expres-
sion and RANKL protein levels, as well as a decrease 
o f   A P   a c t i v i t y .   H i g h   R A N K L   l e v e l s   a n d   l o w   O P G   l e-
vels  lead  to  a  stimulation  of  osteoclasts  via  the 
OPG/RANKL/RANK system [8, 24]. Cell culture and 
animal  studies  of UHMWPE particle induced  osteo-
lysis suggested that the OPG/RANKL/RANK system 
plays an essential role in UHMWPE particle-induced 
bone resorption [3, 25]. Analog to our results, Atkins 
e t   a l .   r e c e n t l y   f o u n d   t h a t   p o l y e t h y l e n e   p a r t i c l e s   l e a d   t o  
increased  RANKL  and  decreased  OPG   [ 1 2 ] .   T h e y  
suggested that PE particles switch mature osteoblastic 
cells from an anabolic to a more catabolic phenotype. 
We were surprised by the mostly non-significant in-
fluence of particles on the OPG mRNA expression. In 
o u r   s t u d y ,   O P G   e x p r e s s i o n   w a s   o n ly  decreased  in 
cell-particle  concentrations  of  1:500  after  72  hours. 
A t k i n s   e t   a l .   f o u n d   c o m p a r a b l e   r e s u l t s   w i t h   a n  
up-r e g u l a t i o n   o f   R A N K L   m R N A   a n d   a  
down-r e g u l a t i o n   o f   O P G   m R N A   7   t o   2 1   d a y s   a f t e r  
p a r t i c l e   t r e a t m e n t   [ 1 2 ] .   T h e   r e s u l t s   o f   o u r   s t u d y   c o r-
respond  to  the  findings  that  macrophage-osteoclast 
differentiation  occurs  in  the  presence  of  soluble 
R A N K L   a n d   t h a t   t h i s   p r o c e s s   i s   i n h i b i t e d   b y   O P G   [ 2 6 ] .  
Up-r e g u l a t i o n   o f   R A N K L   a n d   d o w n -regulation  of 
O P G   a r e   d u a l   e n h a n c e r s   f o r   o s t e o c l a s t   a c t i v i t y ,   p a r-
ticularly  in patients with a large accumulation and 
high concentration of wear particles. Down-regulated 
RANKL  and  up-regulated  OPG  mRNA  expression 
could theoretically inhibit the differentiation and ac-
tivity  of  osteoclasts.  Consequently,  we  suggest  that 
the  discrep a n c y   b e t w e e n   R A N K L   a n d   O P G   m R N A  
expression of osteoblasts affected by UHMWPE par-
ticles is one of the reasons for periprosthetic osteoly-
sis.  
The  results  of  the  AP  activity  after  particle 
treatment correspond to the induction of a catabolic 
phenotype due to UHMWPE particles as described by 
A t k i n s   e t   a l .   [ 1 2 ] .   T h e   n o n -significant  AP  activity 
reaction to different alpha-CGRP levels might be due 
to  the  analyzed  time  course.  Chen  et  al.  found  the 
maximal AP activity after 25 days in hOB cells [27].  
The results after  alpha-CGRP  treatment  under-
line  the  influence  of  the  neurotransmitter  on  parti-
cle-induced osteolysis and a linkage of the nervous 
system  and  particle-induced  osteolysis  as  described 
previously [2, 3]. O u r   s t u d y   s h o w e d   a   s i g n i f i c a n t   i n-
hibition  of  RANKL   p r o d u c t i o n   a f t e r   a l p h a -CGRP 
co-incubation in nearly all particle and alpha-CGRP 
concentrations. These results are comparable to Wang 
et al. who recently described an inhibitory effect of 
alpha-CGRP on osteoclastogenesis and bone resorp-
tion with decreased RANKL expression [28] whereas 
V i l l a   e t   a l .   r e p o r t e d   o n   a   d o w n -r e g u l a t i o n   o f   O P G  
following  alpha-C G R P   t r e a t m e n t   i n   h O B s   [ 1 3 ] .   U n-
fortunately, Villa did not analyze the RANKL expres-
s i o n   i n   h i s   s t u d y ,   a s   t h i s   d o m i n a t e d   i n   o u r   s t u d y .  
Nevertheless,  the  role  of  the  neurotransmitter  al-
pha-C G R P   o n   b o n e   m e t a b o l i s m   h a s   b e e n   c o n t r o v e r-
sial  in  the  past  decade.  Alpha-CGRP  receptors  are 
expressed  in  brain  tissue,  adrenal  and  pituitary 
g l a n d s ,   t h e   e x o c r i n e   p a n c r e a s ,   p e r i p h e r a l   t i s s u e   a n d  
on osteoblasts [29-3 2 ] .   O n   t h e   o n e   h a n d ,   Q i a n   e t   a l .  
found  elevated  CGRP  levels  in  the  synovial  fluids 
f r o m   l o o s e n e d   t o t a l   h i p   a r t h o r p l a s t y   [ 3 3 ] .   O n   t h e   o t h e r  
hand, alpha-CGRP has shown to be a physiological 
activator of bone formation. Cornish et al. found that 
osteoblasts  respond  to  alpha-CGRP  by  increased 
growth [34]. Transgenic mice with an over-expression 
of alpha-CGRP present a phenotype of increased tra-
becular  bone  volume  caused  by  an  increased  bone 
formation  rate  due  to  osteoblast  activity  [35].  Al-
pha-CGRP  knock-out  mice  showed  a  phenotype  of Int. J. Biol. Sci. 2010, 6 
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decreased  bone  formation  and  osteopenia  [36]. 
Moreover,  alpha-CGRP  inhibits  the  differentiation 
a n d   r e c r u i t m e n t   o f   o s t e o c l a s t   p r e c u r s o r s   [ 3 7 ,   3 8 ] .   T h e  
finding that alpha-CGRP favors osteoclast formation 
via  its  pro-osteoclastogenic  effect  on  the 
OPG/RANK/RANKL triad apparently contradicts its 
direct inhibitory action on bone resorption [37, 39].  
C o n t r a r y   t o   t h e   a b o v e   d e s c r i b e d   a n a b o l i c   e f f e c t s  
of alpha-C G R P   t h a t   a r e   i n   l i n e   w i t h   t h e   r e s u l t s   o f   t h i s  
in-v i t r o   s t u d y ,   w e   o b s e r v e d   a   d e c r e a s e   i n   t h e   number 
of  osteoclasts  and  osteolysis  in  the  al-
pha-CGRP-deficient mice after UHMWPE implanta-
t i o n   i n   a   p r e v i o u s   s t u d y   [ 3 ] .   I n   2 0 0 7   w e   h a d   d i f f i c u l t i e s  
to explain the seemingly osteoprotective influence of 
alpha-CGRP.  We  found  a  misbalance  in  the 
OPG/RANKL/RAN K   s y s t e m   a n d   c o n c l u d e d   t h a t   t h e  
alpha-CGRP  deficiency  has  a  complex  influence  on 
bone metabolism in these animals. A disadvantage of 
the  experiment  was  that  the  direct  influence  of  al-
pha-C G R P   w a s   n o t   s t u d i e d   i n   2 0 0 7   b e c a u s e   w e   d i d  
not  substitute  animals  with  alpha-CGRP.  To  further 
analyze the in-v i v o   r e s u l t s   w e   s t a r t e d   w i t h   c e l l -culture 
experiments as these better show the direct influence 
of a single factor. We re-evaluated our previous study 
a n d   b e l i e v e   t h a t   a   d o w n -regulation of osteoclasts and 
osteoblast s   t a k e s   p l a c e .   O n   t h e   o n e   h a n d ,   t h e r e   w e r e  
significantly  less  (p<0.001)  activated  osteoclasts  in 
alpha-C G R P   m i c e   c o m p a r e d   t o   w i l d   t y p e   m i c e .   O n   t h e  
other  hand,  RANKL  staining  of  alpha-CGRP 
knock-out  mice  showed  significantly  less  (p<0.001) 
RANKL indicating either less osteoblast activation or 
less osteoblasts. A decreased bone formation rate of 
these animals has already been described [36]. These 
cell-culture  experiments  describe  an  osteoprotective 
influence  of  alpha-CGRP  on  osteoblasts  comparable 
the in-vi t r o   s t u d y   o f   W a n g   e t   a l .   [ 2 8 ] .   T h e r e f o r e ,   t h e  
conclusion  of  our  in-vivo  study  must  be  discussed 
after  these  in-vitro experiments. For a better under-
standing  of  our  results  in  alpha-CGRP  knock-out 
mice, further in-vivo studies of particle-induced  os-
teolysis with alpha-CGRP substitution or alpha-CGRP 
over-expressing  animals  should  be  undertaken  to 
prove or reject the possible osteoprotective effect of 
alpha-CGRP  substitution  on  particle-induced  osteo-
lysis.  
However,  the  cellular  interactions  involved  in 
the bone resorption phases, i.e. formation, activation 
and survival of osteoblasts/osteoclasts, are subjected 
t o   a   c o m p l e x   o f   o t h e r   f a c t o r s   b e s i d e s  
OPG/RANK/RANKL. Bone remodeling is a tightly 
coupled process consisting of repetitive cycles of bone 
resorption  a n d   f o r m a t i o n .   B o t h   p r o c e s s e s   a r e   g o-
v e r n e d   b y   m e c h a n i c a l   s i g n a l s ,   w h i c h   o p e r a t e   i n   c o n-
j u n c t i o n   w i t h   l o c a l   a n d   s y s t e m i c   f a c t o r s   i n   a   d i s c r e t e  
anatomic structure designated by basic multicellular 
units  (BMU).  Several  pathways  regulating  the  func-
tion of BMU have been reported in the past, including 
TNF-alpha/TNFR/TRAF1  and 
IL-6/CD126/JAK/STAT  [40,  41].  Furthermore,  os-
teoblast activity is strongly regulated by surrounding 
pH and growth factors released from resorbed bone 
matrix that stimulate osteoblasts to promote or inhibit 
b o n e   f o r m a t i o n   [ 4 2 ,   4 3 ] .   T h i s   m a y   h a v e   a n   i m p a c t   o n  
t h e   b o n e   m a s s   o u t c o m e   a t   e a c h   r e m o d e l i n g   c y c l e   [ 4 4 ] .  
M e a n w h i l e ,   t h e   d i r e c t   e f f e c t   o f   a l p h a -C G R P   t o   i n d u c e  
o s t e o b l a s t   p r o l i f e r a t i o n   c a n n o t   b e   i g n o r e d .   I t   h a s   b e e n  
confirmed  that  alpha-CGRP  was  able  to  stimulate 
[3H]thymidine  incorporation  in  human  osteob-
last-l i k e   c e l l s   a n d   i n c r e a s e   c y c l i c   a d e n o s i n e   m o-
nomphsopate  (cAMP)  production  [45,  46].  Protein 
kinase C (PKC) activity, which is important for cell 
proliferation, was also stimulated by this peptide [45].  
Furthermore, wear debris has a direct influence 
on  macrophage-osteoclast  differentiation.  Human 
macrophages  isolated  directly  from  periprosthetic 
tissues surrounding loosened implants can differen-
tiate into multinucleated cells and show all the func-
tional and cytochemical characteristics of osteoclasts 
[ 4 7 ] .   T h e r e f o r e ,   i t   c a n   b e   s u g g e s t e d   t h a t   a l p h a -CGRP, 
by activating bone remodeling, may contribute to the 
precise adjustment of this process favoring the gain or 
l o s s   o f   b o n e   m a s s   d e p e n d i n g   o n  the  local  environ-
ment. Finally, a discrepancy between bone formation 
and resorption due to alpha-CGRP might appear with 
the increase in the concentration of wear particles. 
I t   r e m a i n s   u n c e r t a i n   w h e t h e r   o u r   i n   v i t r o   f i n d-
i n g s   i n   h O B s   c a n   b e   d i r e c t l y   t r a n s f erred  to  an 
up-regulation or down-regulation of bone formation 
in aseptic loosening of joint replacements. A limiting 
f a c t o r   o f   t h i s   s t u d y   i s   t h e   p a r t i a l   f o c u s   o n   t h e   h O B s ,   a s  
t h e   O P G / R A N K L / R A N K   s y s t e m   i n   v i v o   i n t e r a c t s  
between both osteoblasts and osteoclasts.  The  inter-
action  of  osteoclasts  and  osteoblasts  might  have  a 
major impact on the later osteoprotective or catabolic 
result. Furthermore, this cell culture experiment has a 
limited perspective of time as we analyzed the hOBs 
f o r   o n l y   7 2   h o u r s .   A s   a s e p t ic loosening is a process 
w h i c h   c a n   t a k e   y e a r s ,   t h e   r e a c t i o n s   b y   o s t e o b l a s t s  
m i g h t   c h a n g e   i n   t h e   c o u r s e   o f   t i m e .   N e v e r t h e l e s s ,   w e  
can show a significant up-r e g u l a t i o n   o f   R A N K L   e x-
p r e s s i o n   a n d   a n   A P   a c t i v i t y   d e p r e s s i o n   d u e   t o  
UHMWPE particles.  
In  conclusion,   t h e   p r e s e n t   s t u d y   p r o v i d e s   d a t a  
describing  the  activation  of  signaling  pathways  in 
hOBs under incubation with UHMWPE particles. Our 
d a t a   s u p p o r t s   t h e   c o n c e p t   o f   a   l i n k a g e   b e t w e e n   t h e  
peripheral nervous system and aseptic loosening. Our 
results  improve  the  understanding  of  alpha-CGRP Int. J. Biol. Sci. 2010, 6 
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having  an  osteoprotective  influence  on  par-
ticle-induced  osteolysis  via  the 
OPG/RANKL/RANK-system. Further studies of the 
interaction of osteoclasts, osteoblasts, neurotransmit-
ters and the OPG/RANKL/RANK system have to be 
undertaken  to  gain  a  better  understanding  of  the 
multi-factorial process of aseptic loosening and poss-
ible therapeutic options. 
Acknowledgement 
T h e   s t u d y   w a s   s u p p o r t e d   b y   I F O R E S /   U n i v e r-
sity  of  Duisburg-Essen.  The  authors  would  like  to 
thank Kaye Schreyer for editorial assistance with the 
manuscript. 
Conflict of Interests 
T h e   a u t h o r s   h a v e   d e c l a r e d   t h a t   n o   c o n f l i c t   o f   i n-
terest exists. 
References 
1.  Bauer  T.W.  Particles  and  periimplant  bone  resorption.  Clin 
Orthop Relat Res. 2002; 405: 138-43. 
2.  Ahmed M., Bergstrom   J . ,   L u n d b l a d   H . ,   e t   a l .   S e n s o r y   n e r v e s   i n  
the interface membrane of aseptic loose hip prostheses. J Bone 
Joint Surg Br. 1998; 80: 151-5. 
3.  Wedemeyer C., Neuerburg C., Pfeiffer A., et al. Polyethylene 
particle-induced  bone  resorption  in  alpha-calcitonin 
gene-related peptide-deficient mice. J Bone Miner Res. 2007; 22: 
1011-9. 
4.  Beaumont  K.,  Pittner  R.A.,  Moore  C.X.,  et  al.  Regulation  of 
m u s c l e   g l y c o g e n   m e t a b o l i s m   b y   C G R P   a n d   a m y l i n :   C G R P   r e-
ceptors not involved. Br J Pharmacol. 1995; 115: 713-5. 
5.  Leighton   B .   a n d   F o o t   E . A .   T h e   r o l e   o f   t h e   s e n s o r y   p e p t i d e   c a l-
citonin-gene-related peptide(s) in skeletal muscle carbohydrate 
m e t a b o l i s m :   e f f e c t s   o f   c a p s a i c i n   a n d   r e s i n i f e r a t o x i n .   B i o c h e m   J .  
1995; 307 ( Pt 3): 707-12. 
6.  Wimalawansa S.J. Calcitonin gene-related pep t i d e   a n d   i t s   r e-
ceptors: molecular genetics, physiology, pathophysiology, and 
therapeutic potentials. Endocr Rev. 1996; 17: 533-85. 
7.  Wimalawansa  S.J.  Amylin,  calcitonin  gene-related  peptide, 
calcitonin,  and  adrenomedullin:  a  peptide  superfamily.  Crit 
Rev Neurobiol. 1997; 11: 167-239. 
8.  K h o s l a   S .   M i n i r e v i e w :   t h e   O P G / R A N K L / R A N K   s y s t e m .   E n-
docrinology. 2001; 142: 5050-5. 
9.  Y a s u d a   H . ,   S h i m a   N . ,   N a k a g a w a   N . ,   e t   a l .   I d e n t i t y   o f   o s t e o c-
lastogenesis  inhibitory  factor  (OCIF)  and  osteoprotegerin 
(OPG):  a  mechanism  by which OPG/OCIF inhibits osteoclas-
togenesis in vitro. Endocrinology. 1998; 139: 1329-37. 
10.  H o f b a u e r   L . C . ,   K h o s l a   S . ,   D u n s t a n   C . R . ,   e t   a l .   T h e   r o l e s   o f   o s-
teoprotegerin and osteoprotegerin ligand in the paracrine reg-
ulation of bone resorption. J Bone Miner Res. 2000; 15: 2-12. 
11.  G r a n c h i   D . ,   C i a p e t t i   G . ,   A m a t o   I . ,   e t   a l .   The influence of alumina 
and ultra-high molecular weight polyethylene particles on os-
teoblast-osteoclast cooperation. Biomaterials. 2004; 25: 4037-45. 
12.  Atkins G.J., Welldon K.J., Holdi n g   C . A . ,   e t   a l .   T h e   i n d u c t i o n   o f   a  
c a t a b o l i c   p h e n o t y p e   i n   h u m a n   p r i m a r y   o s t e o b l a s t s   a n d   o s t e o-
cytes by polyethylene particles. Biomaterials. 2009; 30: 3672-81. 
13.  Villa I., Mrak E., Rubinacci A., et al. CGRP inhibits osteoprote-
gerin  production  in  human  osteoblast-like  cells  via 
cAMP/PKA-dependent pathway. Am J Physiol Cell Physiol. 
2006; 291: C529-37. 
14.  v o n   K n o c h   M . ,   S p r e c h e r   C . ,   B a r d e n   B . ,   e t   a l .   [Size and shape of 
commercially available polyethylene particles for in-vitro and 
in-vivo-experiments].  Z  Orthop  Ihre  Grenzgeb.  2004;  142: 
366-70. 
15.  Torricelli P., Fini M., Giavaresi G., et al. Comparative interspe-
cies investigation on osteoblast cultures: data on cell viability 
and synthetic activity. Biomedicine & Pharmacotherapy. 2003; 
57: 57-62. 
16.  R a t t n e r   A . ,   S a b i d o   O . ,   L e   J . ,   e t   a l .   M i n e r a l i z a t i o n   a n d   a l k a l i n e  
phosphatase activity in collagen lattices populated by human 
osteoblasts. Calcified Tissue International. 2000; 66: 35-42. 
17.  D i   P a l m a   F . ,   D o u e t   M . ,   B o a c h o n   C . ,   e t   a l .   Physiological strains 
induce differentiation in human osteoblasts cultured on ortho-
paedic biomaterial. Biomaterials. 2003; 24: 3139-3151. 
18.  Guillen  C.,  de  Gortazar  A.R.,  and  Esbrit  P.  The  interleu-
kin-6/soluble interleukin-6   r e c e p t o r   s y s t e m   i n d u c e s   p a r a t h y-
roid hormone-related protein in human osteoblastic cells. Cal-
cified Tissue International. 2004; 75: 153-159. 
19.  Beloti M.M., Martins WJr., Xavier S.P., et al. In vitro osteogene-
sis  induced  by  cells  derived  from  sites  submitted  to  sinus 
grafting with anorganic bovine bone. Clin   O r a l   I m p l a n t s   R e s .  
2008; 19: 48-54. 
20.  Fang H.W., Ho Y.C., Yang C.B., et al. Preparation of UHMWPE 
particles and establishment of inverted macrophage cell model 
to investigate wear particles induced bioactivites. Journal of 
Biochemical and Biophysical Methods. 2006; 68: 175-187. 
21.  Welldon K.J., Atkins G.J., Howie D.W., et al. Primary human 
osteoblasts  grow  into  porous  tantalum  and  maintain  an  os-
teoblastic phenotype. J Biomed Mater Res A. 2008; 84: 691-701. 
22.  Gundle R and Beresford JN. The isolation and culture of cells 
from explants of human trabecular bone. Calcif Tissue Int. 1995; 
56 (Suppl 1): S8-10. 
23.  El-A m i n   S . F . ,   B o t c h w e y   E . ,   T u l i   R . ,   e t   a l .   H u m a n   o s t e o b l a s t  
cells: isolation, characterization, and growth on polymers for 
musculoskeletal  tissue  engineering.  J  Biomed  Mater  Res  A. 
2006; 76: 439-49. 
24.  J a c o b s   J . J . ,   R o e b u c k   K . A . ,   A r c h i b e c k   M . ,   e t   a l .   O s t e o l y s i s :   b a s i c  
science. Clin Orthop Relat Res. 2001; 393: 71-7. 
25.  Ren W., Wu B., Peng X., et al. Implant wear induces inflamma-
tion, but not osteocl a s t i c   b o n e   r e s o r p t i o n ,   i n   R A N K ( -/-) mice. J 
Orthop Res. 2006; 24: 1575-86. 
26.  Itonaga I., Sabokbar A., Murray D.W., et al. Effect of osteopro-
tegerin and osteoprotegerin ligand on osteoclast formation by 
arthroplasty membrane derived macrophages. Ann Rheum   D i s .  
2000; 59: 26-31. 
27.  C h e n   F . P . ,   H s u   T . ,   H u   C . H . ,   e t   a l .   E x p r e s s i o n   o f   e s t r o g e n   r e-
ceptors alfa and beta mRNA and alkaline phosphatase in the 
differentiation  of  osteoblasts  from  elderly  postmenopausal 
women: comparison with osteoblasts from osteosarcoma cell 
lines. Taiwan J Obstet Gynecol. 2006; 45: 307-12. 
28.  Wang L., Shi X., Zhao R., et al. Calcitonin-gene-related peptide 
stimulates stromal cell osteogenic differentiation and inhibits 
RANKL induced NF-kappaB activation, osteoclastogenesis and 
bone resorption. Bone. 2010; 46: 1369-79. 
29.  B j u r h o l m   A . ,   K r e i c b e r g s   A . ,   B r o d i n   E . ,   e t   a l .   S u b s t a n c e   P - and 
CGRP-immunoreactive  nerves  in  bone.  Peptides.  1988;  9: 
165-71. 
30.  Bjurholm A., Kreicbergs A., Terenius L., et al. Neuropeptide Y-, 
tyrosine  hydroxylase-  and  vasoactive  intestinal  polypep-
tide-immunoreactive nerves in bone and surrounding tissues. J 
Auton Nerv Syst. 1988; 25: 119-25. 
31.  Brain S.D. and Williams T.J. Inflammatory oedema induced by 
synergism between calcitonin gene-related peptide (CGRP) and 
mediators of increased vascular permeability. Br J Pharmacol. 
1985; 86: 855-60. Int. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
536 
32.  Y a m a m o t o   I . ,   K i t a m u r a   N . ,   A o k i   J . ,   e t   a l .   H u m a n   c a l c i t o n i n  
gene-related peptide possesses weak inhibitory potency of bone 
resorption in vitro. Calcif Tissue Int. 1986; 38: 339-41. 
33.  Q i a n   Y . ,   Z e n g  B . F . ,   Z h a n g   X . L . ,   e t   a l .   H i g h   l e v e l s   o f   s u b s t a n c e  P  
and CGRP in pseudosynovial fluid from patients with aseptic 
loosening of their hip prosthesis. Acta Orthop. 2008; 79: 342-5. 
34.  Cornish J., Callon K.E., Lin C.Q., et al. Comparison of the effects 
of calcitonin gene-related peptide and amylin on osteoblasts. J 
Bone Miner Res. 1999; 14: 1302-9. 
35.  Ballica R., Valentijn K., Khachatryan A., et al. Targeted expres-
sion of calcitonin gene-related peptide to osteoblasts increases 
bone density in mice. J Bone Miner Res. 1999; 14: 1067-74. 
36.  S c h i n k e   T . ,   L i e s e   S . ,   P r i e m e l   M . ,   e t   a l .   D e c r e a s e d   b o n e   f o r m a t i o n  
and osteopenia in mice lacking alpha-calcitonin gene-related 
peptide. J Bone Miner Res. 2004; 19: 2049-56. 
37.  Akopian A., Demulder A. ,   O u r i a g h l i   F . ,   e t   a l .   E f f e c t s   o f   C G R P  
on human osteoclast-like cell formation: a possible connection 
with the bone loss in neurological disorders? Peptides. 2000; 21: 
559-64. 
38.  Z a i d i   M . ,   F u l l e r   K . ,   B e v i s   P . J . ,   e t   a l .   C a l c i t o n i n   g e n e -related 
peptide  inhibits  osteoclastic  bone  resorption:  a  comparative 
study. Calcif Tissue Int. 1987; 40: 149-54. 
39.  I s h i z u k a   K . ,   H i r u k a w a   K . ,   N a k a m u r a   H . ,   e t   a l .   I n h i b i t o r y   e f f e c t  
of CGRP on osteoclast formation by mouse bone marrow cells 
treated with isoproterenol. Neurosci Lett. 2005; 379: 47-51. 
40.  Dempsey P.W., Doyle S.E., He J.Q., et al. The signaling adaptors 
and pathways activated by TNF superfamily. Cytokine Growth 
Factor Rev. 2003; 14: 193-209. 
41.  Rakshit D.S., Ly K., Sengupta T.K., et al. Wear debris inhibition 
of anti-osteoclastogenic signaling by interleukin-6 and interfe-
ron-gamma.  Mechanistic  insights  and  implications  for  peri-
prosthetic osteolysis. J Bone Joint Surg Am. 2006; 88: 788-99. 
42.  A r n e t t   T . R .   E x t r a c e l l u l a r   p H   r e g u l a t e s   b o n e   c e l l   f u n c t i o n .   J  
Nutr. 2008; 138: 415S-418S. 
43.  S a t o   S . ,   F u t a k u c h i   M . ,   O g a w a   K . ,   e t   a l .   T r a n s f o r m i n g   g r o w t h  
factor beta derived from bone matrix promotes cell prolifera-
tion of prostate cancer and osteoclast activation-associated os-
teolysis  in  the  bone  microenvironment.  Cancer  Sci.  2008; 99: 
316-23. 
44.  Theoleyre S., Wittrant Y., Tat S.K., et al. The molecular triad 
OPG/RANK/RANKL:  involvement  in  the  orchestration  of 
pathophysiological bone remodeling. Cytokine Growth Factor 
Rev. 2004; 15: 457-75. 
45.  Villa  I.,  Dal  Fiume  C.,  M a e s t r o n i   A . ,   e t   a l .   H u m a n   o s t e o b-
last-like  cell  proliferation  induced  by  calcitonin-related  pep-
tides involves PKC activity. Am J Physiol Endocrinol Metab. 
2003; 284: E627-33. 
46.  Villa  I.,  Melzi  R.,  Pagani  F.,  et  al.  Effects  of  calcitonin 
gene-related peptide and amylin on human osteoblast-like cells 
proliferation. Eur J Pharmacol. 2000; 409: 273-8. 
47.  Sabokbar A., Fujikawa Y., Neale S., et al. Human arthroplasty derived 
macrophages differentiate into osteoclastic bone resorbing cells. Ann 
Rheum Dis. 1997; 56: 414-20. 